Literature DB >> 1372161

c-myc protein distribution. Neoplastic tissues of the human colon.

N Tulchin1, L Ornstein, N Harpaz, J Guillem, C Borner, K O'Toole.   

Abstract

There is an extensive literature documenting the increased or deregulated expression of the c-myc oncogene in human malignancies. The authors have recently devised a sensitive immunocytochemical method for studying the tissue localization of c-myc protein in tissue sections of human colon. We have compared nuclear c-myc staining using a polyclonal rabbit anti-c-myc antibody and a mouse monoclonal myc antibody NCM II 274. Microscopic observation of the tissue specific pattern of c-myc protein distribution shows that nuclear staining intensity varies in normal and neoplastic crypt cell nuclei in parallel with morphologic criteria of neoplasia. These studies yield further information on the usefulness of c-myc protein as a prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372161      PMCID: PMC1886156     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  In situ detection of c-myc mRNA in adenocarcinomas, adenomas, and mucosa of human colon.

Authors:  R Mariani-Costantini; C Theillet; P Hutzell; G Merlo; J Schlom; R Callahan
Journal:  J Histochem Cytochem       Date:  1989-03       Impact factor: 2.479

2.  Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

Authors:  V Sundaresan; I C Forgacs; D G Wight; B Wilson; G I Evan; J V Watson
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  Molecular genetic characterization of epitope-specific monoclonal antibodies against the myc family proteins.

Authors:  N Ikegaki; R H Kennett
Journal:  Oncogene       Date:  1990-03       Impact factor: 9.867

4.  Isolation of antibodies specific for avian viral and cellular myc proteins.

Authors:  J H Morgan; T S Papas; J T Parsons
Journal:  J Natl Cancer Inst       Date:  1985-11       Impact factor: 13.506

5.  Distribution of the c-myc oncoprotein in normal and neoplastic tissues of the rat colon.

Authors:  N Tulchin; L Ornstein; J Guillem; K O'Toole; M E Lambert; I B Weinstein
Journal:  Oncogene       Date:  1988-12       Impact factor: 9.867

6.  The v- and c-myc oncogene proteins colocalize in situ with small nuclear ribonucleoprotein particles.

Authors:  D L Spector; R A Watt; N F Sullivan
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

7.  c-myc protein and DNA replication: separation of c-myc antibodies from an inhibitor of DNA synthesis.

Authors:  C Gutierrez; Z S Guo; J Farrell-Towt; G Ju; M L DePamphilis
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

8.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

9.  Sequence-specific DNA binding by the c-Myc protein.

Authors:  T K Blackwell; L Kretzner; E M Blackwood; R N Eisenman; H Weintraub
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

10.  Expression of the myc gene family in different stages of human colorectal cancer.

Authors:  G G Finley; N T Schulz; S A Hill; J R Geiser; J M Pipas; A I Meisler
Journal:  Oncogene       Date:  1989-08       Impact factor: 9.867

View more
  3 in total

Review 1.  Microbiota impact on the epigenetic regulation of colorectal cancer.

Authors:  Tao Yang; Jennifer L Owen; Yaíma L Lightfoot; Michael P Kladde; Mansour Mohamadzadeh
Journal:  Trends Mol Med       Date:  2013-09-16       Impact factor: 11.951

2.  Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.

Authors:  M Saegusa; Y Takano; H Kishimoto; G Wakabayashi; K Nohga; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 3.  Is mucinous carcinoma of the colorectum a distinct genetic entity?

Authors:  C Hanski
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.